Galectins role as predictive markers for anti-PD-1-based immunotherapy in non-small cell lung cancer.

被引：1
|
作者：
Capalbo, Carlo
Filetti, Marco
Scafetta, Giorgia
Marchetti, Paolo
Bartolazzi, Armando
机构：
[1] St Andrea Univ Hosp, Dept Med Oncol, Rome, Italy
[2] St Andrea Univ Hosp, Dept Oncol Pathol, Rome, Italy
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2019年 / 37卷 / 08期
关键词：
D O I：
10.1200/JCO.2019.37.8_suppl.111
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
111
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Treatment outcome and safety of anti-PD-1 antibody against elderly non-small cell lung cancer.
    Sakatani, Toshio
    Saihara, Aya
    Ikushima, Hiroaki
    Takeshima, Hideyuki
    Taniguchi, Yuri
    Hojo, Masayuki
    Usui, Kazuhiro
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [32] Neoadjuvant Immunotherapy in Resectable Non-Small Cell Lung Cancer. A Narrative Review
    Gatteschi, Lavinia
    Iannopollo, Mauro
    Gonfiotti, Alessandro
    LIFE-BASEL, 2021, 11 (10):
  • [33] Multicentre study on the consistency of PD-L1 immunohistochemistry as predictive test for immunotherapy in non-small cell lung cancer
    Butter, Rogier
    't Hart, Nils A.
    Hooijer, Gerrit K. J.
    Monkhorst, Kim
    Speel, Ernst-Jan
    Theunissen, Paul
    Thunnissen, Erik
    Von der Thusen, Jan H.
    Timens, Wim
    van de Vijver, Marc J.
    JOURNAL OF CLINICAL PATHOLOGY, 2020, 73 (07) : 423 - 430
  • [34] THE CHALLENGES OF USING PD-L1 AS A PREDICTIVE BIOMARKER AND THE THERAPEUTIC APPROACH IN NON-SMALL CELL LUNG CANCER IMMUNOTHERAPY
    Patcas, Adela
    Mogosan, Cristina
    Alexescu, Teodora Gabriela
    Bordea, Ioana Roxana
    Buzoianu, Anca Dana
    Todea, Doina Adina
    FARMACIA, 2020, 68 (03) : 390 - 395
  • [35] Intratumoral heterogeneity as a predictive biomarker in anti-PD-(L)1 therapies for non-small cell lung cancer
    Wenfeng Fang
    Haoxuan Jin
    Huaqiang Zhou
    Shaodong Hong
    Yuxiang Ma
    Yaxiong Zhang
    Xiaofan Su
    Longyun Chen
    Yunpeng Yang
    Shengqiang Xu
    Yuwei Liao
    Yuming He
    Hongyun Zhao
    Yan Huang
    Zhibo Gao
    Li Zhang
    Molecular Cancer, 20
  • [36] Predictive biomarkers of response to anti-PD-1 treatment in non-small cell lung cancer patients.
    Zheng, Xuan
    Hu, Yi
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [37] Predictive biomarker of response to anti-PD-1 treatment in non-small cell lung cancer patients.
    Zheng, Xuan
    Hu, Yi
    Ma, Junxun
    Zhang, Fan
    Sun, Danyang
    Li, Lingling
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (05)
  • [38] Intratumoral heterogeneity as a predictive biomarker in anti-PD-(L)1 therapies for non-small cell lung cancer
    Fang, Wenfeng
    Jin, Haoxuan
    Zhou, Huaqiang
    Hong, Shaodong
    Ma, Yuxiang
    Zhang, Yaxiong
    Su, Xiaofan
    Chen, Longyun
    Yang, Yunpeng
    Xu, Shengqiang
    Liao, Yuwei
    He, Yuming
    Zhao, Hongyun
    Huang, Yan
    Gao, Zhibo
    Zhang, Li
    MOLECULAR CANCER, 2021, 20 (01)
  • [39] PD-1 and PD-L1 as immunotherapy targets and biomarkers in non-small cell lung cancer
    Tsoukalas, Nikolaos
    Kiakou, Maria
    Tsapakidis, Konstantinos
    Tolia, Maria
    Aravantinou-Fatorou, Eleni
    Baxevanos, Panagiotis
    Kyrgias, Georgios
    Theocharis, Stamatios
    JOURNAL OF BUON, 2019, 24 (03): : 883 - 888
  • [40] The Emerging Role of Immunotherapy in Resectable Non-Small Cell Lung Cancer
    Dunne, Elizabeth G.
    Fick, Cameron N.
    Isbell, James M.
    Chaft, Jamie E.
    Altorki, Nasser
    Park, Bernard J.
    Spicer, Jonathan
    Forde, Patrick M.
    Gomez, Daniel
    Iyengar, Puneeth
    Harpole Jr, David H.
    Stinchcombe, Thomas E.
    Liberman, Moishe
    Bott, Matthew J.
    Adusumilli, Prasad S.
    Huang, James
    Rocco, Gaetano
    Jones, David R.
    ANNALS OF THORACIC SURGERY, 2024, 118 (01): : 119 - 129
12345